0001209191-18-029966.txt : 20180514
0001209191-18-029966.hdr.sgml : 20180514
20180514175030
ACCESSION NUMBER: 0001209191-18-029966
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180221
FILED AS OF DATE: 20180514
DATE AS OF CHANGE: 20180514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tambi Brian
CENTRAL INDEX KEY: 0001467848
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 18832198
MAIL ADDRESS:
STREET 1: 1925 WEST FIELD COURT SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-21
0
0001516479
Insys Therapeutics, Inc.
INSY
0001467848
Tambi Brian
C/O INSYS THERAPEUTICS, INC.
1333 SOUTH SPECTRUM BLVD, SUITE 100
CHANDLER
AZ
85286
1
0
0
0
Common Stock
2018-02-21
4
A
0
4000
0.00
A
4000
D
Common Stock
2018-05-10
4
M
0
33654
0.61
A
37654
D
Common Stock
2018-05-10
4
M
0
68850
1.62
A
106504
D
Common Stock
2018-05-10
4
M
0
60000
3.63
A
166504
D
Common Stock
2018-05-10
4
S
0
166504
6.41
D
0
D
Restricted Stock Units
2018-02-21
4
D
0
4000
0.00
D
Common Stock
4000
0
D
Stock Option (right to buy)
0.61
2018-05-10
4
M
0
33654
0.00
D
2020-02-21
Common Stock
33654
0
D
Stock Option (right to buy)
1.62
2018-05-10
4
M
0
68850
0.00
D
2021-03-28
Common Stock
68850
0
D
Stock Option (right to buy)
3.63
2018-05-10
4
M
0
60000
0.00
D
2023-05-13
Common Stock
60000
0
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The restricted stock units ("RSUs") vested on the one year anniversary of the date of grant.
The exercise price reflects a 3-for-2 forward stock split effected by the Issuer on March 28, 2014 and a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
The option is fully vested and exercisable.
/s/ Brian Tambi
2018-05-11